Aperam S.A.

/ Key word(s): Strategic Company Decision/Personnel

Aperam Builds on Strong Legacy with Appointment of New CEO 12-Sep-2025 / 08:15 CET/CEST

You might also be interested in reading Inozyme Pharma GAAP EPS of -$0.44 misses by $0.04.